Drug
Cv8102
Cv8102: highest development phase Phase 1, developed by CureVac. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CV8102 NCT03291002 | Phase 1 | Melanoma (Skin) |
| CV8102 NCT02238756 | Phase 1 | Rabies |
Latest
No recent events.
Follow Cv8102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.